The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
|Articles|August 5, 2011
Practical Aspects of Sexual Education
Advertisement
Advertisement
Related to this article
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Evident ovarian cancer screening test: What SOARA will measure
2
Anti-CGRP antibodies associated with higher spontaneous abortion risk
3
FDA approves pritelivir tablets to treat lesions from HSV
4
Wen Shen, MD, on steering patients to evidence-based menopause care
5